Thanks Junaid Mubeen for joining me on the Paradigm podcast to talk about #ArtificialIntelligence and education, and shout out to the legendary Simon Singh and Brilliant.org for inspiring much of this conversation. Enjoy! youtu.be/a_lpyK0aIgA

New preprint. Excellent work by a big collaborative team! Ribosomal DNA copy number is associated with body mass in humans and other mammals | bioRxiv biorxiv.org/content/10.110…

It is fantastic to finally be able to see this paper in print, great collaboration with everyone: nature.com/articles/s4146… MLL-AF4 creates high density enhancer interactions by recruiting a transcription complex including FACT and PAF

The audio version of my best seller on glioblastoma and anaplastic astrocytoma, Glioblastoma: A Guide for Patients and Loved Ones is now available. I hope to reach an audience that might not otherwise have been able to read or access this important book. amazon.co.uk/Glioblastoma-F…

Our latest @EastLondonGenes preprint explores diabetes misclassification in British Bangladeshis and Pakistanis. Fabulous work from Tim Liu, Alagu Sankareswaran and Gordon Paterson. With great colleagues Hilary Martin, Giriraj Chandak, Chittaranjan Yajnik Richard Oram.

Research from Queen Mary, funded by NIHR Barts Biomedical Research Centre and Barts Charity, gives new insight into blood clot risk for women. Read more: qmul.ac.uk/media/news/202…

A massive day for UK trauma with the publication in JAMA of two game-changing trauma trials: cryostat2 and UKREBOATrial. Both turning points in how we understand and treat trauma patients. UK-REBOA: jamanetwork.com/journals/jama/… CRYOSTAT-2: jamanetwork.com/journals/jama/…

Please join us for the @qmulepigenetics seminar by Kristian Tapaninaho from @icr_london 11th Jan. 15.30GMT. venue: Derek Willoughby Lecture Theatre, at our Charterhouse Square campus and online link at qmulepigenetics.com/webinars

Dear 🇬🇧, The usual suspects are at it again, trying to convince you that the NHS — which they destroyed — isn’t fit for purpose and that you need a new healthcare system. They’re dead wrong. Here’s how to challenge them. #SOSNHS

When we have access to advanced human pathology and clinical data, and fantastic new in vitro models that are predictive of human disease, then we have to ask the question - who needs mice? 🐁 🧵

Very happy to share that our new study is out at J Cell Science ! In this work we discussed the contribution of asymmetric mitosis to cancer heterogeneity. Check it out at doi.org/10.1242/jcs.26… LabSinal guido lenz Julieti Buss

Finally, it's "officially" out! Very nice work by Ando et al.. The review process really boosted the quality of this method. Super-resolution microscopy for everyone! eLife - the journal: doi.org/10.7554/eLife.… and building instructions: openuc2.github.io/docs/Investiga… Ewerslab

We have two new faculty opportunities at QMUL, part of a £3.2M investment by Barts Charity to develop genomic and epigenomic liquid biopsy analyses for diagnostics and research applications. More details here: qmulepigenetics.com/jobs Please RT abundantly

Today is #WorldBrainTumourDay! Did you know that 72% of people in the UK can’t name a brain tumour symptom? Use our symptom checker today and make sure you #KnowTheSigns: bit.ly/450kted #BetterSafeThanTumour

The FDA has granted an accelerated approval to tovorafenib (Ojemda) for kids and teens who have low-grade glioma with changes in the BRAF gene. In a small clinical trial, the drug shrank or completely eliminated tumors in nearly 70% of patients. go.nih.gov/UYJcovU #BRAF

Fascinating findings showing histone acetylation is not a consequence of transcription nature.com/articles/s4146…

Data from a trial reported in Nature Medicine show that precision-guided treatment informed by comprehensive molecular profiling significantly improves outcomes for children with high-risk cancers. go.nature.com/4emm6XJ

Important results for #melanoma. Proud of the work with international colleagues, Melanoma Institute Australia & patients and their families - the longest follow up of any of the trials testing now standard drug therapies that save lives. Results impactful - esp for those with V600E #BRAF

Nature research paper: Cellular adaptation to cancer therapy along a resistance continuum go.nature.com/3Wsr7aF

Yesterday, we were visited by Professor Cleo Bishop, who told us all about her incredible research into new treatments for basal-like breast cancer - an aggressive molecular subtype of cancer. Breast cancer is now the most common cancer in the world, and kills one person every